Science Explorer Back to mapMap
Discussion
Topic · Ophthalmology

Ocular Oncology and Treatments

Ocular Oncology and Treatments is a research topic within Ophthalmology. Science Explorer counts 19k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research, diagnosis, and treatment of ocular cancers, particularly uveal melanoma and retinoblastoma. It covers topics such as genetic mutations, metastatic disease, various treatment modalities including radiation therapy and intraocular chemotherapy, prognostic factors, and tumor classification.

  • Uveal Melanoma
  • Retinoblastoma
  • Ocular Surface Neoplasia
  • Metastatic Disease
  • Choroidal Melanoma
  • Genetic Mutations
  • Radiation Therapy
  • Prognostic Factors
  • Intraocular Chemotherapy
  • Tumor Classification
Research works
19k
fractional, since 1950
In the world top 10%
2k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+4%
the tick is no change
Largest producer
United States
35% of the 10 largest, 2022-now
Ocular Oncology and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Ocular Oncology and Treatments research?

By volume, the United States and China publish the most (896 and 499 works in 2022-now).

By volume, 2022-now

  1. 1 United States 896 works
  2. 2 China 499 works
  3. 3 India 340 works
  4. 4 Germany 154 works
  5. 5 United Kingdom 152 works
  6. 6 Japan 120 works
  7. 7 Italy 114 works
  8. 8 France 96 works
  9. 9 Spain 92 works
  10. 10 Türkiye 89 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 35.1%China: 19.6%India: 13.3%Germany: 6.0%6 others listed: 26.0%35%largest
United States896 · 35.1%China499 · 19.6%India340 · 13.3%Germany154 · 6.0%6 others listed664 · 26.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Ocular Oncology and Treatments research?

By volume in 2022-now, Thomas Jefferson University publishes the most Ocular Oncology and Treatments research, followed by All India Institute of Medical Sciences and Capital Medical University.

By volume, 2022-now

  1. 1 Thomas Jefferson UniversityUnited States 57 works
  2. 2 All India Institute of Medical SciencesIndia 49 works
  3. 3 Capital Medical UniversityChina 40 works
  4. 4 Harvard UniversityUnited States 39 works
  5. 5 L V Prasad Eye InstituteIndia 35 works
  6. 6 Shanghai Jiao Tong UniversityChina 33 works
  7. 7 University of MiamiUnited States 27 works
  8. 8 Sun Yat-sen UniversityChina 27 works
  9. 9 University College LondonUnited Kingdom 27 works
  10. 10 Mayo ClinicUnited States 25 works

Who are the leading researchers in Ocular Oncology and Treatments?

The most-cited researchers publishing on Ocular Oncology and Treatments include Jacques Ferlay, Stacey L. Gabriel and Bert Vogelstein.

  1. 1 Jacques Ferlay France 486k citations
  2. 2 Stacey L. Gabriel United States 402k citations
  3. 3 Bert Vogelstein United States 373k citations
  4. 4 Gad A. Getz United States 364k citations
  5. 5 Jost Bruno Jonas Germany 350k citations
  6. 6 Elaine R. Mardis United States 346k citations
  7. 7 Robert A. Weinberg United States 301k citations
  8. 8 Gordon Brent Mills United States 265k citations
  9. 9 Charles M. Perou United States 263k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Ocular Oncology and Treatments?

The most cited paper in Ocular Oncology and Treatments is "Mutation and Cancer: Statistical Study of Retinoblastoma" (Alfred G. Knudson, 1971), with 7,700 citations. Next come "The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product" (3,072) and "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma" (2,994).

Most cited papers
#PaperReleasedCitations
1 Mutation and Cancer: Statistical Study of Retinoblastoma Alfred G. Knudson · Proceedings of the National Academy of Sciences Open access Apr 1971 7,700
2 The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product Nicholas J. Dyson, Peter M. Howley, Karl Münger et al. · Science 17 Feb 1989 3,072
3 A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Stephen Henry Friend, René Bernards, Snezna Rogelj et al. · Nature Open access Oct 1986 2,994
4 Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Caroline Robert et al. · New England Journal of Medicine Open access 16 Nov 2014 2,718
5 Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma Keith T. Flaherty et al. · New England Journal of Medicine Open access 14 Jun 2012 2,179
All 100 most cited papers, with filters and sorting

Where is Ocular Oncology and Treatments research done?

The largest centres of Ocular Oncology and Treatments research in 2022-now are Beijing (China), Philadelphia (United States), Shanghai (China) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Philadelphia.

Largest cities, 2022-now

  1. 1 BeijingChina 83 works
  2. 2 PhiladelphiaUnited States 83 works
  3. 3 ShanghaiChina 67 works
  4. 4 LondonUnited Kingdom 59 works
  5. 5 New DelhiIndia 58 works
  6. 6 New YorkUnited States 57 works
  7. 7 MoscowRussia 55 works
  8. 8 ParisFrance 49 works
  9. 9 GuangzhouChina 42 works
  10. 10 HyderabadIndia 41 works

Where it is the local speciality

  1. PhiladelphiaUS · 82.6 works9.0×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Ocular Oncology and Treatments than the world average.

See Ocular Oncology and Treatments on the map

Where is the best place to study Ocular Oncology and Treatments?

Among universities, judged by research, Harvard University, Leiden University and Thomas Jefferson University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.65%fractional works in this field (log) →share of work in the world top 10% →Leiden UniversityShanghai Jiao Tong U…Harvard UniversityThomas Jefferson Uni…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 70.015.3%3.9×39 +5.9%
2Leiden UniversityNetherlands 69.125.4%10.0×17 -15.1%
3Thomas Jefferson UniversityUnited States 62.98.7%83.5×57 -15.6%
4Shanghai Jiao Tong UniversityChina 62.916.5%3.7×33 +47.0%
5Karolinska InstitutetSweden 62.123.1%4.9×9 +74.2%
6University of Southern CaliforniaUnited States 57.523.8%6.7×18 -14.6%
7Heidelberg UniversityGermany 56.619.4%4.8×12 +44.0%
8University College LondonUnited Kingdom 55.613.0%5.4×27 -6.9%
9Wenzhou Medical UniversityChina 55.422.2%8.0×13 +37.1%
10Columbia UniversityUnited States 54.929.1%3.5×12 -24.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Ocular Oncology and Treatments, country by country

Is Ocular Oncology and Treatments research growing?

Output in 2022-2025 was 4% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Ocular Oncology and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ocular Oncology and Treatments as a percentage of every work published that year, 0.015% in 2024.

still counting0.010%0.020%0.030%Ocular Oncology and Treatments0.015% in 202519801990200020102020

Fractional works of Ocular Oncology and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Ocular Oncology and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Ocular Oncology and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.